# Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.

> **NCT00355342** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 186 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Salmeterol 50 mcg BID
- **DRUG:** Fluticasone Propionate/Salmeterol 250/50 mcg BID
- **DEVICE:** DISKUS inhaler

## Key facts

- **NCT ID:** NCT00355342
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04-28
- **Primary completion:** 2007-09-06
- **Final completion:** 2007-09-06
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355342, "Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00355342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*